A detailed history of Suncoast Equity Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Suncoast Equity Management holds 8,885 shares of EW stock, worth $820,263. This represents 0.1% of its overall portfolio holdings.

Number of Shares
8,885
Previous 8,465 4.96%
Holding current value
$820,263
Previous $645,000 31.63%
% of portfolio
0.1%
Previous 0.09%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$72.54 - $95.56 $30,466 - $40,135
420 Added 4.96%
8,885 $849,000
Q4 2023

Jan 30, 2024

BUY
$61.71 - $77.76 $925 - $1,166
15 Added 0.18%
8,465 $645,000
Q3 2023

Oct 23, 2023

BUY
$69.28 - $93.38 $20,437 - $27,547
295 Added 3.62%
8,450 $585,000
Q2 2023

Aug 07, 2023

BUY
$81.41 - $94.33 $2,605 - $3,018
32 Added 0.39%
8,155 $769,000
Q1 2023

May 08, 2023

BUY
$74.26 - $84.51 $65,942 - $75,044
888 Added 12.27%
8,123 $672,000
Q4 2022

Jan 27, 2023

BUY
$68.3 - $87.44 $23,222 - $29,729
340 Added 4.93%
7,235 $0
Q3 2022

Oct 14, 2022

SELL
$82.37 - $107.29 $78,251 - $101,925
-950 Reduced 12.11%
6,895 $570,000
Q2 2022

Jul 18, 2022

BUY
$86.5 - $128.27 $27,247 - $40,405
315 Added 4.18%
7,845 $746,000
Q1 2022

Apr 26, 2022

BUY
$101.96 - $128.34 $476,153 - $599,347
4,670 Added 163.29%
7,530 $886,000
Q4 2021

Jan 28, 2022

BUY
$106.37 - $130.68 $21,805 - $26,789
205 Added 7.72%
2,860 $371,000
Q3 2021

Oct 29, 2021

BUY
$102.91 - $122.75 $39,620 - $47,258
385 Added 16.96%
2,655 $301,000
Q2 2021

Jul 29, 2021

BUY
$83.84 - $104.76 $190,316 - $237,805
2,270 New
2,270 $235,000
Q1 2021

May 06, 2021

SELL
$78.68 - $90.67 $178,603 - $205,820
-2,270 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$71.69 - $91.23 $162,736 - $207,092
2,270 New
2,270 $207,000
Q1 2020

May 07, 2020

SELL
$52.41 - $81.0 $57,650 - $89,100
-1,100 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$71.7 - $82.09 $78,870 - $90,299
1,100 New
1,100 $257,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Suncoast Equity Management Portfolio

Follow Suncoast Equity Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suncoast Equity Management, based on Form 13F filings with the SEC.

News

Stay updated on Suncoast Equity Management with notifications on news.